171 related articles for article (PubMed ID: 24256535)
1. Reflections from across the Atlantic on SUPPORT, disclosure, consent, and the need for neonatal research.
Hansen TW
Am J Bioeth; 2013; 13(12):39-41. PubMed ID: 24256535
[No Abstract] [Full Text] [Related]
2. The real problem is consent for treatment, not consent for research.
Capron AM
Am J Bioeth; 2013; 13(12):27-9. PubMed ID: 24256529
[No Abstract] [Full Text] [Related]
3. In support of SUPPORT: ignorance and mistrust can harm babies and families.
Janvier A
Am J Bioeth; 2013; 13(12):43-4. PubMed ID: 24256537
[No Abstract] [Full Text] [Related]
4. Let the punishment fit the crime: sensible consent in the management of human subjects research and standard-of-care interventions.
McKinney RE
Am J Bioeth; 2013; 13(12):22-3. PubMed ID: 24256526
[No Abstract] [Full Text] [Related]
5. Are researchers fundamentally untrustworthy in a way that physicians are not?
Rees G; Gainty C
Am J Bioeth; 2013; 13(12):41-2. PubMed ID: 24256536
[No Abstract] [Full Text] [Related]
6. There's a lot we don't know (and we ought to say so).
King NM
Am J Bioeth; 2013; 13(12):20-1. PubMed ID: 24256525
[No Abstract] [Full Text] [Related]
7. Personalized medicine in the NICU.
Barrington KJ
Am J Bioeth; 2013; 13(12):33-5. PubMed ID: 24256532
[No Abstract] [Full Text] [Related]
8. Informed consent and standard of care: what must be disclosed.
Macklin R; Shepherd L
Am J Bioeth; 2013; 13(12):9-13. PubMed ID: 24256523
[TBL] [Abstract][Full Text] [Related]
9. Risk, respect for persons, and informed consent in comparative effectiveness research.
Spellecy R; Leuthner S; Farrell M
Am J Bioeth; 2013; 13(12):46-8. PubMed ID: 24256539
[No Abstract] [Full Text] [Related]
10. The weird divergence of ethics and regulation with regard to informed consent.
Lantos JD
Am J Bioeth; 2013; 13(12):31-3. PubMed ID: 24256531
[No Abstract] [Full Text] [Related]
11. The "research misconception" and the SUPPORT trial: toward evidence-based consensus.
Wilkinson DJ; Gerrand N; Cruz M; Tarnow-Mordi W
Am J Bioeth; 2013; 13(12):48-50. PubMed ID: 24256540
[No Abstract] [Full Text] [Related]
12. Randomization should be disclosed to potential research subjects.
Binik A; Sheehan M
Am J Bioeth; 2013; 13(12):35-7. PubMed ID: 24256533
[No Abstract] [Full Text] [Related]
13. What are reasonably foreseeable risks?
Resnik DB
Am J Bioeth; 2013; 13(12):29-30. PubMed ID: 24256530
[No Abstract] [Full Text] [Related]
14. Ensuring transparency: presenting the trade-offs between the research treatment options.
Schreiner MS
Am J Bioeth; 2013; 13(12):50-2. PubMed ID: 24256541
[No Abstract] [Full Text] [Related]
15. Research on medical practices and the ethics of disclosure.
Magnus D; Wilfond BS
Pediatrics; 2015 Feb; 135(2):208-10. PubMed ID: 25583909
[No Abstract] [Full Text] [Related]
16. Costs to subjects for research participation and the informed consent process: regulatory and ethical considerations.
Iltis AS
IRB; 2004; 26(6):9-13. PubMed ID: 15658017
[No Abstract] [Full Text] [Related]
17. What should be disclosed to research participants?
Wendler D
Am J Bioeth; 2013; 13(12):3-8. PubMed ID: 24256522
[TBL] [Abstract][Full Text] [Related]
18. What must research subjects be told regarding the results of completed randomized trials?
Markman M
IRB; 2004; 26(3):8-10. PubMed ID: 15281194
[No Abstract] [Full Text] [Related]
19. A problem with informed consent.
Weaver JP
J Am Coll Surg; 2009 Aug; 209(2):286; author reply 286-7. PubMed ID: 19632611
[No Abstract] [Full Text] [Related]
20. Randomization and the transactional framework for informed consent.
Reynolds D; Fleming DA
Am J Bioeth; 2009 Feb; 9(2):16-7. PubMed ID: 19180385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
